Community-based antibiotic access and use in six low-income and middle-income countries: a mixed-method approach.
Africa
Anti-Bacterial Agents
/ administration & dosage
Asia
Bangladesh
Developing Countries
Drug Misuse
/ statistics & numerical data
Evaluation Studies as Topic
Female
Ghana
Health Knowledge, Attitudes, Practice
Health Services Accessibility
/ statistics & numerical data
Humans
Male
Mozambique
Poverty
Qualitative Research
Residence Characteristics
South Africa
Surveys and Questionnaires
Thailand
Vietnam
Journal
The Lancet. Global health
ISSN: 2214-109X
Titre abrégé: Lancet Glob Health
Pays: England
ID NLM: 101613665
Informations de publication
Date de publication:
05 2021
05 2021
Historique:
received:
17
06
2020
revised:
12
01
2021
accepted:
13
01
2021
pubmed:
14
3
2021
medline:
29
6
2021
entrez:
13
3
2021
Statut:
ppublish
Résumé
Antimicrobial misuse is common in low-income and middle-income countries (LMICs), and this practice is a driver of antibiotic resistance. We compared community-based antibiotic access and use practices across communities in LMICs to identify contextually specific targets for interventions to improve antibiotic use practices. We did quantitative and qualitative assessments of antibiotic access and use in six LMICs across Africa (Mozambique, Ghana, and South Africa) and Asia (Bangladesh, Vietnam, and Thailand) over a 2·5-year study period (July 1, 2016-Dec 31, 2018). We did quantitative assessments of community antibiotic access and use through supplier mapping, customer exit interviews, and household surveys. These quantitative assessments were triangulated with qualitative drug supplier and consumer interviews and discussions. Vietnam and Bangladesh had the largest proportions of non-licensed antibiotic dispensing points. For mild illness, drug stores were the most common point of contact when seeking antibiotics in most countries, except South Africa and Mozambique, where public facilities were most common. Self-medication with antibiotics was found to be widespread in Vietnam (55·2% of antibiotics dispensed without prescription), Bangladesh (45·7%), and Ghana (36·1%), but less so in Mozambique (8·0%), South Africa (1·2%), and Thailand (3·9%). Self-medication was considered to be less time consuming, cheaper, and overall, more convenient than accessing them through health-care facilities. Factors determining where treatment was sought often involved relevant policies, trust in the supplier and the drug, disease severity, and whether the antibiotic was intended for a child. Confusion regarding how to identify oral antibiotics was revealed in both Africa and Asia. Contextual complexities and differences between countries with different incomes, policy frameworks, and cultural norms were revealed. These contextual differences render a single strategy inadequate and instead necessitate context-tailored, integrated intervention packages to improve antibiotic use in LMICs as part of global efforts to combat antibiotic resistance. Wellcome Trust and Volkswagen Foundation.
Sections du résumé
BACKGROUND
Antimicrobial misuse is common in low-income and middle-income countries (LMICs), and this practice is a driver of antibiotic resistance. We compared community-based antibiotic access and use practices across communities in LMICs to identify contextually specific targets for interventions to improve antibiotic use practices.
METHODS
We did quantitative and qualitative assessments of antibiotic access and use in six LMICs across Africa (Mozambique, Ghana, and South Africa) and Asia (Bangladesh, Vietnam, and Thailand) over a 2·5-year study period (July 1, 2016-Dec 31, 2018). We did quantitative assessments of community antibiotic access and use through supplier mapping, customer exit interviews, and household surveys. These quantitative assessments were triangulated with qualitative drug supplier and consumer interviews and discussions.
FINDINGS
Vietnam and Bangladesh had the largest proportions of non-licensed antibiotic dispensing points. For mild illness, drug stores were the most common point of contact when seeking antibiotics in most countries, except South Africa and Mozambique, where public facilities were most common. Self-medication with antibiotics was found to be widespread in Vietnam (55·2% of antibiotics dispensed without prescription), Bangladesh (45·7%), and Ghana (36·1%), but less so in Mozambique (8·0%), South Africa (1·2%), and Thailand (3·9%). Self-medication was considered to be less time consuming, cheaper, and overall, more convenient than accessing them through health-care facilities. Factors determining where treatment was sought often involved relevant policies, trust in the supplier and the drug, disease severity, and whether the antibiotic was intended for a child. Confusion regarding how to identify oral antibiotics was revealed in both Africa and Asia.
INTERPRETATION
Contextual complexities and differences between countries with different incomes, policy frameworks, and cultural norms were revealed. These contextual differences render a single strategy inadequate and instead necessitate context-tailored, integrated intervention packages to improve antibiotic use in LMICs as part of global efforts to combat antibiotic resistance.
FUNDING
Wellcome Trust and Volkswagen Foundation.
Identifiants
pubmed: 33713630
pii: S2214-109X(21)00024-3
doi: 10.1016/S2214-109X(21)00024-3
pmc: PMC8050200
pii:
doi:
Substances chimiques
Anti-Bacterial Agents
0
Types de publication
Evaluation Study
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
e610-e619Subventions
Organisme : Wellcome Trust
ID : 109595/Z/15/Z
Pays : United Kingdom
Commentaires et corrections
Type : CommentIn
Informations de copyright
Copyright © 2021 The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY 4.0 license. Published by Elsevier Ltd.. All rights reserved.
Références
BMC Public Health. 2020 Jul 29;20(1):1183
pubmed: 32727445
Lancet Infect Dis. 2013 Dec;13(12):1057-98
pubmed: 24252483
Lancet Infect Dis. 2011 Sep;11(9):692-701
pubmed: 21659004
Am J Epidemiol. 2013 Feb 15;177(4):361-70
pubmed: 23364878
Am J Trop Med Hyg. 2019 Jun;100(6):1378-1390
pubmed: 30994091
Lancet. 2016 Jan 9;387(10014):188-98
pubmed: 26603919
Int J Qual Health Care. 2007 Dec;19(6):349-57
pubmed: 17872937
Trop Med Int Health. 2012 Feb;17(2):211-22
pubmed: 21999394
J Pharm Policy Pract. 2018 Dec 14;11:30
pubmed: 30564369
Lancet Planet Health. 2018 Sep;2(9):e398-e405
pubmed: 30177008
Wellcome Open Res. 2017 Jul 28;2:58
pubmed: 29707652
Lancet Infect Dis. 2014 Aug;14(8):742-750
pubmed: 25022435
Lancet Glob Health. 2016 Sep;4(9):e633-41
pubmed: 27495137
J Clin Pharm Ther. 2018 Apr;43(2):302-307
pubmed: 29205419
BMC Public Health. 2019 Nov 26;19(1):1560
pubmed: 31771536
Antibiotics (Basel). 2020 Nov 07;9(11):
pubmed: 33171743
Lancet. 2007 Oct 20;370(9596):1453-7
pubmed: 18064739
Proc Natl Acad Sci U S A. 2018 Apr 10;115(15):E3463-E3470
pubmed: 29581252
BMC Public Health. 2020 Jul 14;20(1):1103
pubmed: 32664902
BMJ. 2016 Feb 29;352:i1202
pubmed: 26926703
Lancet Glob Health. 2019 Jan;7(1):e119-e131
pubmed: 30554748
BMC Public Health. 2019 Jul 22;19(1):971
pubmed: 31331304
J Antimicrob Chemother. 2019 Sep 1;74(9):2788-2796
pubmed: 31257435
Isr Med Assoc J. 2007 Jan;9(1):16-20
pubmed: 17274349
Lancet Infect Dis. 2020 Feb;20(2):179-187
pubmed: 31843383
Ann Fam Med. 2009 Nov-Dec;7(6):520-6
pubmed: 19901311
Res Social Adm Pharm. 2019 Jun;15(6):627-631
pubmed: 30279131
BMC Public Health. 2015 Aug 01;15:742
pubmed: 26231758
Int J Epidemiol. 2013 Oct;42(5):1309-18
pubmed: 24159076
Public Health. 2019 Mar;168:92-101
pubmed: 30716570
Front Public Health. 2020 Mar 24;8:90
pubmed: 32266200